David Elliot Lazar
CEO, Chairman & Interim CFO and Principal Financial OfficerMr. David Elliot Lazar is Chief Executive Officer and Director of Highway Holdings Limited from November 4, 2026. He has been the Interim Chief Financial Officer and Interim Principal Financial Officer at Aterian, Inc. since September 04, 2026. He is CEO of Quantum Cyber N.V. from April 22, 2026. He was Temporary Non-Executive Director and Chair at Quantum Cyber N.V. (formerly known as Mainz Biomed N.V.) since February 13, 2026 and serves as Director. He was Chair of the Board & CEO of Sow Good Inc. from December 31, 2025 until March 31, 2026 and served as its Director since December 31, 2025 until May 6, 2026. Mr. Lazar is Independent Director of Aterian, Inc. from April 26, 2026 and serves as its Chief Executive Officer from July 17, 2026 and serves as its Chairman of the Board since July 2026. Mr. Lazar was Director of Indaptus Therapeutics, Inc. from March 18, 2026 to June 05, 2026. Mr. Lazar was Chairman & Co-CEO of Indaptus Therapeutics, Inc. from December 2025 until March 18, 2026. He is CEO, CFO & Chairman of Humitech International Group, Inc. and serves as Director. He has been CEO and Chairman of Humitech since July 6. 2023. He was Chairman of KALA BIO, Inc. from December 1, 2025 until February 16, 2026 and was its President & Chief Operating Officer until February 16, 2026. He was CFO & CEO of KALA BIO, Inc. until February 02, 2026. Mr. Lazar was CEO & Director of NovaBay Pharmaceuticals, Inc. from August 19, 2025 until October 9, 2025. Mr. Lazar had been President of OpGen, Inc. from August 02, 2024 until January 8, 2026. He serves as Chief Executive Officer and Chairman at MEDO Technologies, Inc. (formerly known as Byrn Inc.) (formerly known as Born Inc.) since July 6. 2023. Mr. Lazar served as interim Chief Executive Officer and principal financial officer of Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC), from January 2, 2025 through February 26, 2025. Mr. Lazar also served as the president and a member of the board of directors of LQR House Inc. (NASDAQ: YHC) from October 2024 to April 2025. He serves as President, Treasurer, Chief Financial Officer, Secretary and Sole Director at MEDO Technologies, Inc. (formerly known as Byrn Inc.) (formerly known as Born Inc.) He had been Chief Business Development Officer of TRACON Pharmaceuticals, Inc. from May 7, 2024 until June 19, 2024. He was Chairman and CEO of OpGen, Inc. from March 25, 2024 until August 02, 2024. Mr. Lazar served as Chief Executive Officer, President, Secretary, Chief Financial Officer, Director of UBuyHoldings, Inc. since July 26, 2023 until June 24, 2024 and served as its Chairman since July 26, 2023 until June 24, 2024. Mr. Lazar had been the Chief Executive Officer of FiEE, Inc. (formerly known as Minim, Inc.) since January 2024 until February 26, 2025. He was Director of FiEE, Inc. (formerly known as Minim, Inc.) from December 28, 2023 to June 30, 2025 and served as its Chairman and also served as its Chief Financial Officer from January 01, 2024. He served as Chief Executive Officer and Principal Financial Officer of Titan Pharmaceuticals, Inc. since August 15, 2022 and August 16, 2022 respectively and had been its Interim Chairman since August 15, 2022 until October 12, 2023. Mr. Lazar serves as an Advisor to PROMAX Investments LLC, a position he has held since July 2022 and as an Ambassador at Large for the Arab African Council for Integration and Development, since March 2022. He serves as Chairman and Chief Executive Officer of Bitmis Corp. since December 30, 2021 and its Treasurer and Secretary. He served as Chairman and Chief Executive Officer at Zenosense, Inc. since December 30, 2021 until September 28, 2022. He was President and Chief Financial Officer of Zenosense, Inc. until September 28, 2022. He served as Treasurer and Secretary at Zenosense, Inc. until September 28, 2022. He serves as Chief Executive Officer, President, Secretary, Chief Financial Officer, Chief Executive Officer and Chairman of the Board of Directors. at Momentous Holdings Corp. since July 6, 2023. He served as Chief Executive Officer and Chairman of Shengshi Elevator International Holding Group Inc. since December 30, 2020 until January 5, 2022. He had been Chief Executive Officer, President, Secretary, Chief Financial Officer and Chairman of the Board at ESP Resources, Inc. since January 7, 2021 until August 31, 2021 and had been its Treasurer until August 31, 2021. He had been Secretary and Chief Financial Officer at Energy 1 Corporation since July 10, 2020 until July 13, 2021. Mr. Lazar served as President, Secretary and Chief Financial Officer of Shengshi Elevator International Holding Group Inc. since May 18, 2021 until January 5, 2022. He served as Treasurer of Shengshi Elevator International Holding Group Inc until January 5, 2022. He served as President, Secretary, Chief Financial Officer, Chief Executive Officer and Chairman of the Board at China Botanic Pharmaceutical Inc. since February 4, 2021 until August 24, 2021. Mr. Lazar served as Chairman, Chief Executive Officer, President, Treasurer and Secretary of Moveix Inc. since December 30, 2020 until July 2, 2021. Mr. Lazar served as the President, Chief Executive Officer, Secretary, Chief Financial Officer and Chairman of the Board at Arax Holdings Corp. since December 30, 2020 until June 24, 2021 and served as its Treasurer until June 24, 2021. He served as Chief Executive Officer, Chief Financial Officer and Director at Ketdarina Corp. since December 16, 2020 until April 14, 2021 and served as its President, Secretary and Chairman of the Board of Directors since December 16, 2020. He served as Chairman and CEO of Balincan International Inc. since August 18, 2021 until February 09, 2022 and also served as its Secretary and Treasurer until February 09, 2022. He served as an Independent Director at IR-Med Inc. since November 2018 until June 27, 2022. He served as President, Chief Executive Officer, Treasurer, Chief Financial Officer, Secretary and Director at International Luxury Products Inc. since August 29, 2019. He has been Chairman of the Board, President, Chief Executive Officer, Secretary and Chief Financial Officer at One 4 Art Limited since December 16, 2020. He served as the President, Treasurer, Secretary and sole Director at Quture International, Inc. since December 31, 2019 until September 23, 2020 and served as its Chief Executive Officer and Chief Financial Officer until September 23, 2020. He has been Chairman, President, CEO, CFO & Secretary at Adorbs Inc. since July 2020 and serves as its Director. He is a private Investor with business experience. He served as Chairman, President, Chief Executive Officer, Chief Financial Officer and Secretary at PhoneBrasil (PHBR) since August 2020 until December 09, 2020. He was Director, Chief Executive Officer and Chief Financial Officer of Magna-Lab Inc. since July 18, 2020 until October 12, 2020. Mr. Lazar served as Chief Executive Officer and Chairman of the Board at Health Revenue Assu
Positions
- Company NameAterian, Inc.Stock CodeATERPositionCEO, Chairman & Interim CFO and Principal Financial Officer
- Company NameHighway Holdings LimitedStock CodeHIHOPositionCEO & Director
- Company NameQuantum Cyber N.V.Stock CodeQUCYPositionCEO & DirectorColleagues
- WJWilliam J. CaragolCFO & Senior VP
- RPRobert P. LiscouskiIndependent Chairman of the Board
- DEDavid Elliot LazarCEO & Director
- CVChristopher Von ToerneChief Operating Officer
- DSDennis SchnurHead of U.S. Sales
- SEStefan ErlachHead of Human Resources
- DNDavid NatanIndependent Non-Executive Director
- ASAvraham Shlomo Ben-TzviIndependent Non-Executive Director
- STSoren Thestrup-NielsenMember of Strategic Advisory Board
